NCT04068597 2025-12-18
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
CellCentric Ltd.
Phase 1/2 Recruiting
CellCentric Ltd.
University of Vermont
Sanofi
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
University Hospital, Toulouse
Karyopharm Therapeutics Inc